T

TLC Research | Los Angeles, California

Research site
(Unclaimed)
Location
9631 W 3rd Street Suite 815E, Los Angeles, California, United States of America
Site insights

Top conditions

Parkinson Disease (3 trials)

Seizures (1 trial)

Panic Disorder (1 trial)

Top treatments

Tavapadon
Darigabat
CVL-865

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder

The purpose of this trial is to measure the efficacy, safety, and tolerability of darigabat (25 milligrams [mg] twice daily [BID]) compared with plac...

Enrolling
Panic Disorder
Drug: Placebo
Drug: Darigabat

The purpose of this study is to assess the efficacy, safety, and tolerability profile of CVL-865 as adjunctive treatment in participants with drug-re...

Enrolling
Seizures
Drug: CVL-865
Drug: Placebo

The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics (PK) of 2 fixed doses of tavapadon and placebo in partici...

Active, not recruiting
Parkinson Disease
Drug: Tavapadon
Drug: Placebo
Recently updated

The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Park...

Invitation-only
Parkinson Disease
Drug: Tavapadon

Trial sponsors

Cerevel Therapeutics logo

Cerevel Therapeutics (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems